Senior Scientist 1, Research Biology (Neuroscience) - Eikon Therapeutics

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

As a Senior Scientist I, you will be a key player in developing complex cellular models and enable target discovery and validation for Parkinson’s disease.

About You

We are seeking an enthusiastic and capable Senior Scientist I to join our Neuroscience research team. You are a strong communicator and work well in a team. You are passionate about advancing research within Neuroscience.

What You'll Do

• Execution of in vitro experiments in cell lines, primary neurons, iPSC-derived neurons and glia culture.
• Build and execute biochemical and cell-based assays to support novel Parkinson’s disease target validation.
• Collaborate with and support cellular and molecular biologists, in vivo pharmacologists and medicinal chemists across research sites.
• Support the training and guidance of junior research associates and interns, fostering a collaborative and productive research environment.
• Stay up-to-date with the latest advancements in Parkinson’s Disease research by attending relevant conferences and workshops.
• Contribute to the preparation of research publications, presentations, and grant proposals, showcasing the team's contributions to the field.
• Maintain organized and comprehensive records of experiments, results, and protocols in adherence to company standards and regulatory requirements.
• Uphold a culture of safety by strictly following laboratory protocols and promoting best practices in accordance with regulatory guidelines.

Qualifications

• Typically Postdoc fellowship plus 2 years; or Ph.D. plus 5 years of relevant experience; or Master's plus 14 years of relevant experience; or Bachelor's plus 16 years of relevant experience in Neuroscience or Cell Biology, Biochemistry, Pharmacology.
• Experience in Parkinson’s disease or related neurodegenerative disease research preferred. Prior experience in drug discovery a plus.
• Highly proficient in cell culture techniques, including primary neurons and glia. Experience in iPSC-derived cells and/or complex co-culture model systems an asset.
• Proficiency with standard cell biology, biochemistry, enzymology and neuroscience techniques including confocal microscopy/high-content imaging, protein detection & quantification (such as ELISA, MSD), and enzyme kinetic assays.
• Extensive bench research experience and enjoy a laboratory-focused role in a fast-paced, multidisciplinary team.
• Ability to design, execute and interpret experiments independently.
• Excellent written and verbal communication.
• Strong interpersonal and teamwork skills paired with a strong work ethic.

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

• 401k plan with company matching​
• Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
• Mental health and wellness benefits​
• Weeklong summer and winter holiday shutdowns​
• Generous paid time off and holiday policies​
• Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
• Enhanced parental leave benefit​
• Daily subsidized lunch program when on-site​

The expected salary range for this role is $134,000 to $146,300 depending on skills, competency, and the market demand for your expertise.

Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

In accordance with the Company’s duty to provide and maintain a safe workplace, the Company requires all employees to be Fully Vaccinated with one of the FDA approved COVID-19 vaccines, which includes those vaccines that have received the FDA’s emergency use authorization. You will be expected to be Fully Vaccinated as of your Start Date. If you believe that you are exempt from this requirement under an applicable law or regulations, including Americans with Disabilities Act and California’s Fair Employment and Housing Act, you will need to contact the Company’s Human Resources group. For purposes of this section, Fully Vaccinated means (i) the completion of the vaccination regimen as approved by the FDA (by way of example, 2 doses of the Pfizer or Moderna vaccine and 1 dose of the Johnson and Johnson vaccine), and (ii) timely receiving booster vaccination, as recommended by the Centers for Disease Control and Prevention.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.